Ligand profile
ZINC40545038
Virtual-screening candidate from ZINC.
Bound to: VK055_2384 — methionine aminopeptidase, type I
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC40545038- UniProt (similar protein)
P0AE18- Tanimoto
- 0.791
- Target protein
- VK055_2384
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 108.6
- −1 ≤ LogP ≤ 5 1.96
- MW ≤ 500 Da 262.2
- LogP ≤ 5 1.96
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 108.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1ccc([N+](=O)[O-])cc1-c1ccc(C(N)=O)o1COc1ccc([N+](=O)[O-])cc1-c1ccc(C(N)=O)o1
InChI=1S/C12H10N2O5/c1-18-9-3-2-7(14(16)17)6-8(9)10-4-5-11(19-10)12(13)15/h2-6H,1H3,(H2,13,15)InChI=1S/C12H10N2O5/c1-18-9-3-2-7(14(16)17)6-8(9)10-4-5-11(19-10)12(13)15/h2-6H,1H3,(H2,13,15)
TWJDWGTWRJGSJF-UHFFFAOYSA-NTWJDWGTWRJGSJF-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL369971
- Homolog
- P0AE18
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC40545038 →
- ZINC ZINC20 ZINC40545038 →
- UniProt UniProt P0AE18 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC40545038”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2384.
PDB 46
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).